アーユルヴェーダの世界市場

アーユルヴェーダの世界市場は2030年までに728億米ドルに達する見込み

2024年に178億米ドルと推定されるアーユルヴェーダの世界市場は、2024年から2030年にかけてCAGR 26.5%で成長し、2030年には728億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるハーバルフォームは、CAGR 28.1％を記録し、分析期間終了時には458億米ドルに達すると予測されます。ミネラル形態セグメントの成長率は、分析期間でCAGR 24.4％と推定されます。

米国市場は48億米ドルと推定、中国はCAGR 35.1％で成長予測

米国のアーユルヴェーダ市場は、2024年には48億米ドルになると推定されます。世界第2位の経済大国である中国は、2030年までに182億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは35.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ21.2%と23.9%と予測されています。欧州では、ドイツがCAGR約22.4%で成長すると予測されています。

世界のアーユルヴェーダ市場- 主要動向と促進要因のまとめ

なぜアーユルヴェーダは復活を遂げたのか？

アーユルヴェーダ市場は、ナチュラルでホリスティックなヘルスケアソリューションに対する消費者の嗜好の高まりにより成長しています。伝統医療やウェルネス療法に対する意識の高まりにより、アーユルヴェーダ製剤の需要が高まっています。政府によるアーユルヴェーダ調査への支援や、ハーブ医薬品に対する世界の規制当局の承認が、市場の成長をさらに後押ししています。さらに、アーユルヴェーダ・スキンケア、栄養補助食品、個別化されたウェルネス・プログラムの拡大により、業界の提供品目は多様化しています。アーユルヴェーダが主流のヘルスケアに組み込まれ、現代医療と統合されたことも業界の急拡大に寄与しています。ヘルスケアコストの増加や合成医薬品の副作用に対する懸念が、多くの消費者を自然で予防的なヘルスケアアプローチに向かわせ、アーユルヴェーダの世界の普及を後押ししています。

技術の進歩はアーユルヴェーダ市場をどのように形成しているか？

アーユルヴェーダ業界は、バイオテクノロジー、抽出技術、製剤科学の進歩により、大きな変革期を迎えています。最新の調査手法により、アーユルヴェーダ医薬品の標準化と品質管理が可能になり、その有効性と安全性が確保されています。AIとビッグデータ解析は、遺伝的素因とライフスタイル要因に基づいてパーソナライズされたアーユルヴェーダ治療計画を作成するために採用されています。さらに、ナノ製剤やカプセル化技術により、アーユルヴェーダ・ハーブの生物学的利用能が向上し、治療効果が高まっています。デジタルヘルスプラットフォームと遠隔医療は、アーユルヴェーダのリーチをさらに拡大し、消費者がオンラインで専門家の相談や個人に合わせたハーブ療法にアクセスできるようにしています。

なぜ世界プレーヤーや投資家はアーユルヴェーダ市場への参入を増やしているのでしょうか？

アーユルヴェーダ市場は、世界ヘルスケア企業、新興企業、ベンチャーキャピタルから多額の投資を集めています。主要製薬企業や化粧品企業は、ナチュラル・ウェルネス・ソリューションに対する需要の高まりに対応するため、アーユルヴェーダ製品ラインを発売しています。アーユルヴェーダ製剤、スキンケア、栄養補助食品では、業界を超えたコラボレーションがイノベーションを促進しています。欧米市場でアーユルヴェーダが受け入れられつつあることで、アーユルヴェーダ・ブランドは国際的な地域に進出し、ハーブ療法に対する消費者の関心が高まっています。さらに、研究資金、輸出奨励金、規制枠組みを通じてアーユルヴェーダを促進する政府の取り組みが業界の信頼を高め、新規参入と事業拡大を後押ししています。

アーユルヴェーダ市場の主な成長促進要因は？

アーユルヴェーダ市場の成長は、自然療法やホリスティックヘルスケアの人気の高まり、アーユルヴェーダ製剤の研究の増加、アーユルヴェーダと現代医療との融合など、いくつかの要因によって牽引されています。化学物質を含まない美容・パーソナルケア製品に対する消費者の嗜好が、アーユルヴェーダのスキンケアや化粧品の需要をさらに拡大しています。特にパンデミック後の予防ヘルスケアやセルフケアの動向の高まりは、アーユルヴェーダの免疫力向上やウェルネス製品の採用を加速させています。さらに、伝統医療を支援する政府の取り組みやeコマースプラットフォームの拡大により、アーユルヴェーダ製品は世界中の人々にとってより身近なものとなっています。アーユルヴェーダ病院、ウェルネス・リトリート、代替療法センターの存在感の高まりは、消費者の信頼と業界の成長をさらに促進し、アーユルヴェーダを世界の主流ウェルネス・ソリューションとして位置づけています。

セグメント

形態（ハーブ形態、ミネラル形態、ハーブミネラル形態）、適応症（皮膚・毛髪適応症、消化管適応症、感染症適応症、呼吸器系適応症、神経系適応症、循環器系適応症、その他適応症）、流通チャネル（直販流通チャネル、通信販売流通チャネル、電子販売流通チャネル）、用途（個人用途、医療・治療用途）、最終用途（クリニック最終用途、病院最終用途、学術・研究最終用途）

調査対象企業の例

• Amrutanjan Health Care Ltd.
• Bioveda Action Research Company
• Charak Pharma Pvt. Ltd.
• Cancer Research UK
• Dabur India Ltd
• Forest Essentials
• Hamdard Laboratories
• Himalaya Wellness Company
• Kerala Ayurveda Ltd.
• Patanjali Ayurved Limited
• Shree Baidyanath Ayurved Bhawan Pvt. Ltd.
• The Arya Vaidya Pharmacy（Coimbatore）Ltd.
• Vicco Laboratories

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Ayurveda Market to Reach US$72.8 Billion by 2030

The global market for Ayurveda estimated at US$17.8 Billion in the year 2024, is expected to reach US$72.8 Billion by 2030, growing at a CAGR of 26.5% over the analysis period 2024-2030. Herbal Form, one of the segments analyzed in the report, is expected to record a 28.1% CAGR and reach US$45.8 Billion by the end of the analysis period. Growth in the Mineral Form segment is estimated at 24.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.8 Billion While China is Forecast to Grow at 35.1% CAGR

The Ayurveda market in the U.S. is estimated at US$4.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$18.2 Billion by the year 2030 trailing a CAGR of 35.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 21.2% and 23.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 22.4% CAGR.

Global Ayurveda Market - Key Trends & Drivers Summarized

Why Is Ayurveda Experiencing a Resurgence?

The Ayurveda market is growing due to increasing consumer preference for natural and holistic healthcare solutions. The rising awareness of traditional medicine and wellness therapies has led to higher demand for Ayurvedic formulations. Government support for Ayurveda research and global regulatory approvals for herbal medicines have further propelled market growth. Additionally, the expansion of Ayurvedic skincare, nutraceuticals, and personalized wellness programs has diversified industry offerings. The incorporation of Ayurveda into mainstream healthcare and its integration with modern medical practices have also contributed to the industry’s rapid expansion. Increasing healthcare costs and concerns over the side effects of synthetic drugs have driven many consumers toward natural and preventive healthcare approaches, boosting Ayurveda’s adoption worldwide.

How Are Technological Advancements Shaping the Ayurveda Market?

The Ayurveda industry is undergoing significant transformation due to advancements in biotechnology, extraction techniques, and formulation sciences. Modern research methodologies have enabled the standardization and quality control of Ayurvedic medicines, ensuring their efficacy and safety. AI and big data analytics are being employed to create personalized Ayurvedic treatment plans based on genetic predisposition and lifestyle factors. Additionally, nano-formulations and encapsulation technologies have improved the bioavailability of Ayurvedic herbs, enhancing their therapeutic potential. Digital health platforms and telemedicine are further expanding Ayurveda’s reach, allowing consumers to access expert consultations and personalized herbal remedies online.

Why Are Global Players and Investors Increasingly Entering the Ayurveda Market?

The Ayurveda market is attracting substantial investments from global healthcare companies, startups, and venture capital firms. Leading pharmaceutical and cosmetic companies are launching Ayurvedic product lines to cater to the rising demand for natural wellness solutions. Cross-industry collaborations are fostering innovation in Ayurvedic formulations, skincare, and dietary supplements. The increasing acceptance of Ayurveda in Western markets has led to the expansion of Ayurvedic brands into international territories, with growing consumer interest in herbal remedies. Furthermore, government initiatives promoting Ayurveda through research funding, export incentives, and regulatory frameworks have bolstered industry confidence, encouraging new entrants and business expansion.

What Are the Key Growth Drivers of the Ayurveda Market?

The growth of the Ayurveda market is driven by several factors, including the rising popularity of natural and holistic healthcare, increasing research into Ayurvedic formulations, and the integration of Ayurveda with modern medical practices. Consumer preference for chemical-free beauty and personal care products has further expanded the demand for Ayurvedic skincare and cosmetics. The rising trend of preventive healthcare and self-care, especially post-pandemic, has accelerated the adoption of Ayurvedic immunity-boosting and wellness products. Additionally, government initiatives supporting traditional medicine, along with the expansion of e-commerce platforms, have made Ayurvedic products more accessible to a global audience. The increasing presence of Ayurvedic hospitals, wellness retreats, and alternative therapy centers is further driving consumer trust and industry growth, positioning Ayurveda as a mainstream wellness solution worldwide.

SCOPE OF STUDY:

The report analyzes the Ayurveda market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Form (Herbal Form, Mineral Form, Herbomineral Form); Indication (Skin/Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication, Cardiovascular Systems Indication, Other Indications); Distribution Channel (Direct Sales Distribution Channels, Distance Correspondence Distribution Channels, E-Sales Distribution Channels); Application (Personal Application, Medical/Therapy Application); End-Use (Clinics End-Use, Hospitals End-Use, Academia and Research End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Amrutanjan Health Care Ltd.
• Bioveda Action Research Company
• Charak Pharma Pvt. Ltd.
• Cancer Research UK
• Dabur India Ltd
• Forest Essentials
• Hamdard Laboratories
• Himalaya Wellness Company
• Kerala Ayurveda Ltd.
• Patanjali Ayurved Limited
• Shree Baidyanath Ayurved Bhawan Pvt. Ltd.
• The Arya Vaidya Pharmacy (Coimbatore) Ltd.
• Vicco Laboratories

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Ayurveda - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Global Shift Toward Holistic Wellness and Preventive Healthcare Throws the Spotlight on Ayurveda as a Mainstream Alternative
  • Rising Consumer Demand for Natural and Plant-Based Products Propels Growth of Ayurvedic Personal Care and Nutrition
  • Increased Focus on Immunity, Stress Relief, and Lifestyle Management Accelerates Adoption of Ayurveda Post-Pandemic
  • Expansion of Ayurvedic Offerings in E-Commerce and DTC Channels Strengthens Market Reach and Consumer Accessibility
  • Integration of Ayurveda with Modern Diagnostics and Wellness Platforms Expands the Addressable Market in Functional Health
  • Innovation in Ayurvedic Formulations and Standardized Extracts Spurs Growth in Nutraceutical and Cosmeceutical Segments
  • Digitization of Ayurvedic Consultations and Personalized Wellness Apps Reinforces Ayurveda's Position in Tech-Enabled Healthcare
  • Rising Demand for Clean Label and Chemical-Free Alternatives Sustains Long-Term Interest in Ayurvedic Skincare and Haircare
  • Urbanization and Lifestyle Disorders Create Opportunities for Ayurvedic Solutions in Stress, Sleep, and Metabolic Health
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Ayurveda Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Ayurveda by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Ayurveda by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Ayurveda by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Herbal Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Herbal Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Herbal Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Mineral Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Mineral Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Mineral Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Herbomineral Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Herbomineral Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Herbomineral Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Skin / Hair Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Skin / Hair Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Skin / Hair Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for GI Tract Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for GI Tract Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for GI Tract Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Infectious Diseases Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Infectious Diseases Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Infectious Diseases Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Personal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Personal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Personal Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Medical / Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Medical / Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Medical / Therapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Academia & Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Academia & Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Academia & Research End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Respiratory System Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Respiratory System Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Respiratory System Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Nervous System Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Nervous System Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Nervous System Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Cardiovascular System Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Cardiovascular System Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Cardiovascular System Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Direct Sales Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Direct Sales Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Direct Sales Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Distance Correspondence Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Distance Correspondence Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Distance Correspondence Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for E-Sales Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for E-Sales Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for E-Sales Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 59: USA Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: USA 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 62: USA Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: USA 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 65: USA Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: USA 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 68: USA Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: USA 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: USA 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Canada 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Canada 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Canada 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 83: Canada Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Canada Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Canada 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 86: Canada Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Canada Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Canada 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• JAPAN
  • Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Japan 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 92: Japan Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Japan Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Japan 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 95: Japan Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Japan Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Japan 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 98: Japan Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Japan Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Japan 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 101: Japan Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Japan Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Japan 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• CHINA
  • Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 104: China Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: China Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: China 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 107: China Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: China Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: China 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 110: China Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: China Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: China 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 113: China Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: China Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: China 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 116: China Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: China Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: China 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• EUROPE
  • Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 119: Europe Recent Past, Current & Future Analysis for Ayurveda by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 120: Europe Historic Review for Ayurveda by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Europe 15-Year Perspective for Ayurveda by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 122: Europe Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Europe Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Europe 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 125: Europe Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Europe Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Europe 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 128: Europe Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Europe Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Europe 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 131: Europe Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Europe Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Europe 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 134: Europe Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Europe Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Europe 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• FRANCE
  • Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 137: France Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: France Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: France 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 140: France Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: France Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: France 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 143: France Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: France Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: France 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 146: France Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: France Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: France 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 149: France Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: France Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: France 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• GERMANY
  • Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 152: Germany Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Germany Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Germany 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 155: Germany Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Germany Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Germany 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 158: Germany Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Germany Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Germany 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 161: Germany Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Germany Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Germany 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 164: Germany Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Germany Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Germany 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 167: Italy Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Italy Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Italy 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 170: Italy Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Italy Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Italy 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 173: Italy Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Italy Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Italy 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 176: Italy Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Italy Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Italy 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 179: Italy Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Italy Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Italy 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 182: UK Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: UK Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: UK 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 185: UK Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: UK Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: UK 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 188: UK Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: UK Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: UK 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 191: UK Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: UK Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: UK 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 194: UK Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: UK Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: UK 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 197: Spain Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Spain Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Spain 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 200: Spain Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Spain Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Spain 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 203: Spain Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Spain Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Spain 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 206: Spain Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Spain Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Spain 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 209: Spain Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Spain Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Spain 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 212: Russia Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Russia Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Russia 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 215: Russia Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Russia Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Russia 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 218: Russia Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Russia Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Russia 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 221: Russia Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Russia Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Russia 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 224: Russia Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Russia Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Russia 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 227: Rest of Europe Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Europe Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Europe 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 230: Rest of Europe Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Europe Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Europe 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Europe Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Europe Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Europe 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Europe Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Europe Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Europe 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Europe Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Europe Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Europe 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 242: Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 243: Asia-Pacific Historic Review for Ayurveda by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Asia-Pacific 15-Year Perspective for Ayurveda by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 245: Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Asia-Pacific Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Asia-Pacific 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 248: Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Asia-Pacific Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Asia-Pacific 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 251: Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Asia-Pacific Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Asia-Pacific 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 254: Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Asia-Pacific Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Asia-Pacific 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 257: Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Asia-Pacific Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Asia-Pacific 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 260: Australia Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Australia Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Australia 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 263: Australia Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Australia Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Australia 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 266: Australia Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Australia Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Australia 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 269: Australia Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Australia Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Australia 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 272: Australia Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Australia Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Australia 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• INDIA
  • Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 275: India Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: India Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: India 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 278: India Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: India Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: India 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 281: India Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: India Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: India 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 284: India Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: India Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: India 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 287: India Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: India Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: India 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 290: South Korea Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: South Korea Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: South Korea 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 293: South Korea Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: South Korea Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: South Korea 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 296: South Korea Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: South Korea Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: South Korea 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 299: South Korea Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: South Korea Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: South Korea 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 302: South Korea Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: South Korea Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: South Korea 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 305: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Asia-Pacific Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Asia-Pacific 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Asia-Pacific Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Asia-Pacific 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Asia-Pacific Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Asia-Pacific 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Asia-Pacific Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Asia-Pacific 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Asia-Pacific Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Asia-Pacific 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 320: Latin America Recent Past, Current & Future Analysis for Ayurveda by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 321: Latin America Historic Review for Ayurveda by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Latin America 15-Year Perspective for Ayurveda by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 323: Latin America Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Latin America Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Latin America 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 326: Latin America Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Latin America Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Latin America 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 329: Latin America Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Latin America Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Latin America 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 332: Latin America Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Latin America Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Latin America 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 335: Latin America Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Latin America Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Latin America 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 338: Argentina Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Argentina Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Argentina 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 341: Argentina Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Argentina Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Argentina 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 344: Argentina Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Argentina Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Argentina 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 347: Argentina Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Argentina Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Argentina 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 350: Argentina Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Argentina Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Argentina 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 353: Brazil Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Brazil Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Brazil 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 356: Brazil Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Brazil Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Brazil 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 359: Brazil Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Brazil Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Brazil 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 362: Brazil Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Brazil Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Brazil 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 365: Brazil Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Brazil Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Brazil 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 368: Mexico Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Mexico Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Mexico 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 371: Mexico Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Mexico Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Mexico 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 374: Mexico Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Mexico Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Mexico 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 377: Mexico Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Mexico Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Mexico 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 380: Mexico Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Mexico Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Mexico 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 383: Rest of Latin America Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Latin America Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Latin America 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Latin America Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Latin America Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Latin America 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Latin America Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Latin America Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Latin America 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 392: Rest of Latin America Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Latin America Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Rest of Latin America 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 395: Rest of Latin America Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Latin America Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Rest of Latin America 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 398: Middle East Recent Past, Current & Future Analysis for Ayurveda by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 399: Middle East Historic Review for Ayurveda by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Middle East 15-Year Perspective for Ayurveda by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 401: Middle East Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Middle East Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Middle East 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 404: Middle East Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Middle East Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Middle East 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 407: Middle East Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Middle East Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Middle East 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 410: Middle East Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Middle East Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 412: Middle East 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 413: Middle East Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Middle East Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 415: Middle East 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 416: Iran Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Iran Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 418: Iran 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 419: Iran Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Iran Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 421: Iran 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 422: Iran Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 423: Iran Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 424: Iran 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 425: Iran Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 426: Iran Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 427: Iran 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 428: Iran Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 429: Iran Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 430: Iran 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 431: Israel Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 432: Israel Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 433: Israel 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 434: Israel Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 435: Israel Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 436: Israel 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 437: Israel Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 438: Israel Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 439: Israel 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 440: Israel Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 441: Israel Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 442: Israel 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 443: Israel Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 444: Israel Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 445: Israel 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 446: Saudi Arabia Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 447: Saudi Arabia Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 448: Saudi Arabia 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 449: Saudi Arabia Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 450: Saudi Arabia Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 451: Saudi Arabia 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 452: Saudi Arabia Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 453: Saudi Arabia Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 454: Saudi Arabia 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 455: Saudi Arabia Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 456: Saudi Arabia Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 457: Saudi Arabia 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 458: Saudi Arabia Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 459: Saudi Arabia Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 460: Saudi Arabia 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 461: UAE Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 462: UAE Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 463: UAE 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 464: UAE Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 465: UAE Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 466: UAE 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 467: UAE Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 468: UAE Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 469: UAE 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 470: UAE Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 471: UAE Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 472: UAE 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 473: UAE Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 474: UAE Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 475: UAE 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 476: Rest of Middle East Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 477: Rest of Middle East Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 478: Rest of Middle East 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 479: Rest of Middle East Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 480: Rest of Middle East Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 481: Rest of Middle East 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 482: Rest of Middle East Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 483: Rest of Middle East Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 484: Rest of Middle East 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 485: Rest of Middle East Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 486: Rest of Middle East Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 487: Rest of Middle East 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 488: Rest of Middle East Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 489: Rest of Middle East Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 490: Rest of Middle East 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
• AFRICA
  • Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 491: Africa Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 492: Africa Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 493: Africa 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
  • TABLE 494: Africa Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 495: Africa Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 496: Africa 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory System Indication, Nervous System Indication and Cardiovascular System Indication for the Years 2015, 2025 & 2030
  • TABLE 497: Africa Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 498: Africa Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 499: Africa 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channel, Distance Correspondence Distribution Channel and E-Sales Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 500: Africa Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 501: Africa Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 502: Africa 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
  • TABLE 503: Africa Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 504: Africa Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 505: Africa 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION